<DOC>
	<DOCNO>NCT00583414</DOCNO>
	<brief_summary>The purpose study assess role abdominal aneurysm iliac aneurysm exclusion use endovascular prosthesis .</brief_summary>
	<brief_title>Endovascular Exclusion Abdominal Aortic Aneurysms High Risk Patients</brief_title>
	<detailed_description>This study prospective , non-randomized evaluation endovascular aneurysm repair high-risk patient . The purpose study determine whether endovascular prosthesis safe effective intend use treat AAA/iliac aneurysm patient high risk standard aneurysm surgical repair . Up 400 patient enrolled Cleveland clinic Foundation . Baseline procedure may include angiogram , intravascular ultrasound , CT scan , physical exam , blood work ankle-brachial index . The endovascular prosthesis place operating room regional general anesthesia procedure length approximately 2-3 hour . Follow evaluation do 1 month , 6 month ( clinically necessary ) , 12 month yearly , may include physical exam , CT scan , KUB , ultrasound , blood work , ankle-brachial index .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<mesh_term>Iliac Aneurysm</mesh_term>
	<criteria>The aneurysm &gt; /= 5 cm large , high risk rupture due shape , history growth , symptom , presence large ( &gt; 2 cm ) iliac aneurysm Anticipated mortality great 10 percent conventional surgery Life expectancy great 2 year Suitable arterial anatomy Absence systemic disease allergy precludes endovascular repair Capable give informed consent willingness comply followup schedule Pregnancy History anaphylactic reaction contrast material inability properly prophylax patient appropriately Allergy stainless steel polyester Unwilling comply followup schedule Serious systemic groin infection Coagulopathy , coumadin therapy Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>